THOMAS C FREYMAN
CIK 1239126 · Executive Vice President · last filed 2026-05-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$96.92M
Companies
5
Total Filings
89
Lifetime Open-Market Net
-$6.25M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ABBV | Director | 129,810 | $262.35 | $34.06M | $0 | 8 | 2026-05-12 |
| HANGER, INC. (HNGR) Delisted | Director | 0 | $18.72 | $0 | $0 | 5 | 2022-10-04 |
| TEN | Director | 93,892 | $42.51 | $3.99M | $510.8K | 17 | 2022-02-02 |
| Allergan plc (AGN) Delisted | Director | 0 | — | — | $209.8K | 5 | 2020-05-11 |
| ABT | Executive Vice President | 514,682 | $114.38 | $58.87M | -$6.97M | 51 | 2016-07-29 |
Recent Filings · Page 2 of 9
89 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-11 | ABBV | Grant (A) | +1,681 | $0 | EDGAR |
| 2021-02-04 | TEN | Grant (A) | +10,850 | $0 | EDGAR |
| 2020-08-07 | TEN | Buy (P) | +30,000 | $231.0K | EDGAR |
| 2020-05-22 | ABBV | Grant (A) | +4,916 | $0 | EDGAR |
| 2020-05-21 | HANGER, INC. (HNGR) Delisted | Grant (A) | +8,178 | $0 | EDGAR |
| 2020-05-12 | ABBV | Grant (A) | +4,916 | $0 | EDGAR |
| 2020-05-11 | Allergan plc (AGN) Delisted | Disp (D) | −2,983 | $0 | EDGAR |
| 2020-05-04 | Allergan plc (AGN) Delisted | Tax (F) | −2,064 | -$391.6K | EDGAR |
| 2020-02-06 | TEN | Grant (A) | +12,208 | $0 | EDGAR |
| 2019-05-24 | HANGER, INC. (HNGR) Delisted | Grant (A) | +6,969 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.